AR030912A1 - Uso de derivados monosacaridos triciclicos y sus sales para preparar un medicamento para prevenir o tratar la neurodegeneracion inducida por isquemia, derivados monosacaridos triciclicos y sales y composiciones farmaceuticas que los comprenden - Google Patents

Uso de derivados monosacaridos triciclicos y sus sales para preparar un medicamento para prevenir o tratar la neurodegeneracion inducida por isquemia, derivados monosacaridos triciclicos y sales y composiciones farmaceuticas que los comprenden

Info

Publication number
AR030912A1
AR030912A1 ARP000103837A ARP000103837A AR030912A1 AR 030912 A1 AR030912 A1 AR 030912A1 AR P000103837 A ARP000103837 A AR P000103837A AR P000103837 A ARP000103837 A AR P000103837A AR 030912 A1 AR030912 A1 AR 030912A1
Authority
AR
Argentina
Prior art keywords
monosacaridate
tricycle
derivatives
pharmaceutical compositions
neurodegeneration
Prior art date
Application number
ARP000103837A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of AR030912A1 publication Critical patent/AR030912A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Los compuestos anticonvulsivos de formula general (1): en donde X, R1, R2, R3, R4, R5, y R6 son como se definen en la memoria, son utiles para prevenir o tratar la neurodegeneracion inducida por isquemia, tal como ocurre durante y después de un derrame cerebral, trauma cefálico, lesion de la médula espinal, ataque cardíaco no fatal, o procedimientos quirurgicos mayores. Y composiciones farmacéuticas que los contienen así como el uso de los mismos para preparar medicamentos.
ARP000103837A 1999-07-26 2000-07-25 Uso de derivados monosacaridos triciclicos y sus sales para preparar un medicamento para prevenir o tratar la neurodegeneracion inducida por isquemia, derivados monosacaridos triciclicos y sales y composiciones farmaceuticas que los comprenden AR030912A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14561899P 1999-07-26 1999-07-26

Publications (1)

Publication Number Publication Date
AR030912A1 true AR030912A1 (es) 2003-09-03

Family

ID=22513879

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103837A AR030912A1 (es) 1999-07-26 2000-07-25 Uso de derivados monosacaridos triciclicos y sus sales para preparar un medicamento para prevenir o tratar la neurodegeneracion inducida por isquemia, derivados monosacaridos triciclicos y sales y composiciones farmaceuticas que los comprenden

Country Status (15)

Country Link
US (1) US6495523B1 (es)
EP (1) EP1204669B1 (es)
JP (1) JP2003505465A (es)
AR (1) AR030912A1 (es)
AT (1) ATE309261T1 (es)
AU (1) AU775296B2 (es)
CA (1) CA2380208A1 (es)
CY (1) CY1105359T1 (es)
DE (1) DE60023910T2 (es)
DK (1) DK1204669T3 (es)
ES (1) ES2252033T3 (es)
MX (1) MXPA02000924A (es)
NZ (1) NZ516783A (es)
TW (1) TW559558B (es)
WO (1) WO2001007453A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242942A (en) 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
US5258402A (en) 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
NZ277725A (en) 1993-12-23 1998-04-27 Ortho Pharma Corp Pseudofructopyranose sulphamate derivatives, preparation and pharmaceutical compositions thereof
US5498629A (en) * 1993-12-23 1996-03-12 Ortho Pharmaceutical Corporation Anticonvulsant pseudofructopyranose sulfamates
WO1998000124A1 (en) * 1996-06-28 1998-01-08 Ortho Pharmaceutical Corporation Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of postischemic neurodegeneration
WO2000050020A2 (en) * 1999-02-24 2000-08-31 University Of Cincinnati Use of sulfamate derivatives for treating impulse control disorders

Also Published As

Publication number Publication date
DE60023910D1 (de) 2005-12-15
AU6357700A (en) 2001-02-13
ATE309261T1 (de) 2005-11-15
MXPA02000924A (es) 2003-07-14
CA2380208A1 (en) 2001-02-01
EP1204669A1 (en) 2002-05-15
TW559558B (en) 2003-11-01
DK1204669T3 (da) 2006-02-20
ES2252033T3 (es) 2006-05-16
AU775296B2 (en) 2004-07-29
WO2001007453A1 (en) 2001-02-01
CY1105359T1 (el) 2010-03-03
JP2003505465A (ja) 2003-02-12
NZ516783A (en) 2005-03-24
EP1204669B1 (en) 2005-11-09
DE60023910T2 (de) 2006-07-20
US6495523B1 (en) 2002-12-17

Similar Documents

Publication Publication Date Title
AR025444A1 (es) Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos
ES2175161T3 (es) Derivados de piperazina como antagonistas de taquiquinina.
WO2005011655A3 (en) Pyridazine derivatives and their use as therapeutic agents
WO2005011653A3 (en) Pyridazine derivatives and their use as therapeutic agents
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
PA8591701A1 (es) Derivados de pirrolopirimidina
AR029175A1 (es) Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento
ES2161290T3 (es) Derivados de quinazolina.
ECSP045483A (es) Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso
AR033346A1 (es) Acido aminoalcano carboxilicos, un procedimiento para su preparacion, intermediarios, y el uso de los mismos para la manufactura de un medicamento
AR006678A1 (es) Derivados de macrolidas triciclicas, una composicion farmaceutica que los contiene, uso de los mismos para preparar medicamentos y procedimientopara su preparacion
BRPI0409427A (pt) composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo
BRPI0418004A (pt) composto ou um sal, solvato, solvato de um tal sal ou uma pró-droga deste farmaceuticamente aceitáveis, métodos para tratar ou prevenir condições hiperlipidêmicas, aterosclerose, mal de alzheimer, e tumores associados com colesterol, formulação farmacêutica, combinação, e, processo para preparar um composto ou um sal, solvato, solvato de um tal sal ou uma pró-droga deste farmaceuticamente aceitáveis
BR0316690A (pt) Composto, prodroga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, composição farmacêutica, e processo para a preparação de um composto
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
AR010894A1 (es) Aminoacidos aromaticos biciclicos, un procedimiento para prepararlos, preparaciones farmaceuticas que lo contienen y el empleo de los mismos parapreparar un medicamento que actua como inhibidor de la integrina.
UY28356A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
DE60233276D1 (de) Verfahren zur Herstellung der Natrium Salze von Retinoylderivaten
AR026267A1 (es) Agentes heterociclicos citotoxicos.
DE69824313D1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
UY28357A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparación de los mismos y sus usos
AR030912A1 (es) Uso de derivados monosacaridos triciclicos y sus sales para preparar un medicamento para prevenir o tratar la neurodegeneracion inducida por isquemia, derivados monosacaridos triciclicos y sales y composiciones farmaceuticas que los comprenden
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
DE602004022783D1 (de) Heterozyklische harnstoff-derivate für die behandlung von schmerzen.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal